Ketohexokinase Activators

The chemical class Ketohexokinase Activators includes compounds that can indirectly influence KHK activity through their effects on metabolic pathways, energy states, and insulin sensitivity. Insulin and glucagon play significant roles in regulating glucose and fructose metabolism, thereby potentially influencing KHK activity. Metformin, by improving insulin sensitivity, may also have an indirect effect on KHK activity. Fructose, being a direct substrate of KHK, can enhance its activity when available in higher concentrations. Compounds like AMP, which reflect cellular energy states, may also indirectly modulate KHK's function.

PPAR-gamma agonists, Rosiglitazone and Pioglitazone, alter metabolic pathways in a way that can influence KHK. Acarbose, by impacting carbohydrate digestion, can indirectly affect fructose availability and hence KHK activity. Additionally, the primary energy source, glucose, plays a crucial role in metabolic pathways, and its altered metabolism can influence KHK activity. Furthermore, Rapamycin, an inhibitor of mTOR, affects cellular metabolism, which can impact KHK activity. Epinephrine and Norepinephrine, through their roles in glycogenolysis and lipolysis, can influence metabolic pathways and potentially impact KHK activity.